2022-07-01T08:45:41.3823680Z
https://www.termdat.bk.admin.ch/entry/479262
Swissmedic, MM Swissmedic prüft Impfstoffkandidaten von Moderna, 2020-11-13 ([Internet, 2020-11-17](https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-81112.html))
Swissmedic, PR Swissmedic reviews vaccine candidate from Moderna, 2020-11-13 ([Internet, 2020-11-17](https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-81112.html))
Swissmedic, Comm. pr. Swissmedic examine un dossier pour un candidat vaccin de l’entreprise Moderna, 2020-11-13 ([Internet, 2020-11-17](https://www.admin.ch/gov/fr/accueil/documentation/communiques.msg-id-81112.html))
UFSP, CS Vaccino anti-COVID-19: la Confederazione firma un contratto con AstraZeneca, 2020-10-16 ([Internet, 2020-11-17](https://www.bag.admin.ch/bag/it/home/das-bag/aktuell/medienmitteilungen.msg-id-80732.html))
DOM: Covid-19-Pandemie; EXP: Impfstoff, der von Swissmedic noch nicht zugelassen worden ist
DOM: COVID-19 pandemic; EXP: vaccine that has not yet been authorised by Swissmedic
DOM: pandémie de COVID-19; EXP: vaccin qui n'a pas encore été autorisé par Swissmedic
DOM: pandemia di COVID-19; EXP: vaccino che non è ancora stato omologato da Swissmedic
nach Swissmedic, MM Swissmedic prüft Impfstoffkandidaten von Moderna, 2020-11-13 ([Internet, 2020-11-17](https://www.admin.ch/gov/de/start/dokumentation/medienmitteilungen.msg-id-81112.html))
after Swissmedic, PR Swissmedic reviews vaccine candidate from Moderna, 2020-11-13 ([Internet, 2020-11-17](https://www.admin.ch/gov/en/start/documentation/media-releases.msg-id-81112.html))
d'après Swissmedic, Comm. pr. Swissmedic examine un dossier pour un candidat vaccin de l’entreprise Moderna, 2020-11-13 ([Internet, 2020-11-17](https://www.admin.ch/gov/fr/accueil/documentation/communiques.msg-id-81112.html))
secondo Swissmedic, CS Swissmedic esamina il potenziale vaccino di Moderna ([Internet, 2020-11-17](https://www.admin.ch/gov/it/pagina-iniziale/documentazione/comunicati-stampa.msg-id-81112.html))